Alexandra Bastiany, MD, made history when she became Canada’s first Black female interventional cardiologist in 2020. Now, that achievement is being recognized in a surprising way.

“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."

New research suggests that the tissue environment where microcalcifications of the breast are formed could hold clues into how breast cancer progresses.

The device, which gained FDA approval in 2021, was part of a voluntary recall in 2022 due to stability concerns. Medtronic worked with the FDA to address the issue, and the Harmony TPV is once again available throughout the United States. 

Given the less invasive nature of focused ultrasound procedures, researchers suggest that it could open the door for disease management options catered to a wider variety of patients.

The 3D-printed models are soft, flexible and can mimic the way a patient's heart may respond to different interventions. 

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology.